
Thermo Fisher Scientific Inc
NYSE:TMO

US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
419.31
623.3502
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

Intrinsic Value
The intrinsic value of one
TMO
stock under the Base Case scenario is
524.29
USD.
Compared to the current market price of 423.67 USD,
Thermo Fisher Scientific Inc
is
Undervalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Thermo Fisher Scientific Inc
Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.

Valuation History
Historical valuation for TMO cannot be conducted due to limitations such as insufficient data or other constraints.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:

Thermo Fisher’s significant reliance on government-funded research budgets makes it vulnerable to potential cuts in public R&D spending, which could slow its top-line growth and margin expansion in the event of policy shifts.
Recent large-scale acquisitions pose integration risks and potential margin dilution if Thermo Fisher cannot execute synergy targets and effectively align acquired businesses under its operational umbrella.
A decline in COVID-19 testing demand, which contributed heavily to revenue during the pandemic, could result in near-term comparability challenges, exposing lower organic growth rates across other business segments.
Thermo Fisher’s extensive portfolio of scientific instruments, lab consumables, and diagnostic equipment creates a one-stop shop for research institutions, driving recurring revenue streams through cross-selling and high customer retention.
Its strategic acquisitions, such as Life Technologies, have enhanced Thermo Fisher’s capabilities in genetic testing and advanced diagnostics, positioning it to benefit from long-term trends in personalized medicine and biotech innovation.
Strong cash generation and a robust balance sheet allow the company to reinvest in R&D and pursue targeted acquisitions, fueling continuous product development and expansion into high-growth sectors like cell and gene therapy.

Revenue & Expenses Breakdown
Thermo Fisher Scientific Inc
Balance Sheet Decomposition
Thermo Fisher Scientific Inc
Current Assets | 23.4B |
Cash & Short-Term Investments | 5.9B |
Receivables | 8.5B |
Other Current Assets | 9B |
Non-Current Assets | 75.7B |
PP&E | 9.3B |
Intangibles | 61.8B |
Other Non-Current Assets | 4.5B |
Current Liabilities | 13.2B |
Other Current Liabilities | 13.2B |
Non-Current Liabilities | 36.5B |
Long-Term Debt | 31.4B |
Other Non-Current Liabilities | 5.1B |
Free Cash Flow Analysis
Thermo Fisher Scientific Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Thermo Fisher Scientific Inc
Revenue
|
42.9B
USD
|
Cost of Revenue
|
-25.1B
USD
|
Gross Profit
|
17.8B
USD
|
Operating Expenses
|
-10B
USD
|
Operating Income
|
7.8B
USD
|
Other Expenses
|
-1.3B
USD
|
Net Income
|
6.5B
USD
|
TMO Profitability Score
Profitability Due Diligence
Thermo Fisher Scientific Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Score
Thermo Fisher Scientific Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
TMO Solvency Score
Solvency Due Diligence
Thermo Fisher Scientific Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Score
Thermo Fisher Scientific Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TMO Price Targets Summary
Thermo Fisher Scientific Inc
According to Wall Street analysts, the average 1-year price target for
TMO
is 639.15 USD
with a low forecast of 479.75 USD and a high forecast of 805.35 USD.
Dividends
Current shareholder yield for TMO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
TMO
stock under the Base Case scenario is
524.29
USD.
Compared to the current market price of 423.67 USD,
Thermo Fisher Scientific Inc
is
Undervalued by 19%.